LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4035 | 4093 | 0.9860 | 0.9801 |
MCF7 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3784 | 4093 | 0.9246 | 0.8930 |
MCF7 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3261 | 4093 | 0.7967 | 0.7115 |
MCF7 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2769 | 4093 | 0.6765 | 0.5408 |
MCF7 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1240 | 4093 | 0.3031 | 0.0108 |
MCF7 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 874 | 4093 | 0.2135 | -0.1164 |
MCF7 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2358 | 4093 | 0.5763 | 0.3985 |
MCF7 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3650 | 4093 | 0.8919 | 0.8466 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3908 | 4093 | 0.9548 | 0.9358 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3456 | 4093 | 0.8445 | 0.7793 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2527 | 4093 | 0.6176 | 0.4571 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1550 | 4093 | 0.3788 | 0.1182 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3892 | 4093 | 0.9509 | 0.9303 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1881 | 4093 | 0.4596 | 0.2329 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3549 | 4093 | 0.8673 | 0.8116 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3742 | 4093 | 0.9144 | 0.8785 |
MCF7 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3933 | 4093 | 0.9609 | 0.9445 |
MCF7 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 668 | 4093 | 0.1634 | -0.1876 |
MCF7 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 712 | 4093 | 0.1740 | -0.1724 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3607 | 4093 | 0.8814 | 0.8317 |
MCF7 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3746 | 4093 | 0.9154 | 0.8799 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4175 | 4093 | 1.0201 | 1.0286 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3523 | 4093 | 0.8608 | 0.8024 |
MCF7 | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3956 | 4093 | 0.9667 | 0.9527 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2258 | 4093 | 0.5518 | 0.3637 |